Urologix Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
14,771.00
12,571.00
17,027.00
16,590.00
14,012.00
Cost of Goods Sold (COGS) incl. D&A
6,593.00
6,054.00
8,735.00
8,237.00
8,211.00
Gross Income
8,178.00
6,517.00
8,292.00
8,353.00
5,801.00
SG&A Expense
10,435.00
10,243.00
12,609.00
12,503.00
9,714.00
EBIT
2,257.00
3,726.00
4,317.00
4,256.00
3,913.00
Unusual Expense
-
-
172.00
540.00
3,017.00
Non Operating Income/Expense
-
-
13.00
7.00
1.00
Interest Expense
-
-
482.00
555.00
693.00
Pretax Income
2,257.00
3,725.00
4,640.00
4,278.00
7,624.00
Income Tax
88.00
8.00
55.00
14.00
16.00
Consolidated Net Income
2,169.00
3,733.00
4,695.00
4,292.00
7,608.00
Net Income
2,169.00
3,733.00
4,695.00
4,292.00
7,608.00
Net Income After Extraordinaries
2,169.00
3,733.00
4,695.00
4,292.00
7,608.00
Net Income Available to Common
2,169.00
3,733.00
4,695.00
4,292.00
7,608.00
EPS (Basic)
0.15
0.26
0.32
0.21
0.36
Basic Shares Outstanding
14,508.00
14,556.00
14,741.00
20,703.00
21,219.00
EPS (Diluted)
0.15
0.26
0.32
0.21
0.36
Diluted Shares Outstanding
14,508.00
14,556.00
14,741.00
20,703.00
21,219.00
EBITDA
1,464.00
3,161.00
3,622.00
3,581.00
3,326.00
Other Operating Expense
-
-
-
106.00
-
Non-Operating Interest Income
-
1.00
-
-
-
About Urologix
View Profile
